index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

LncARN Multiresolution modeling Becker muscular dystrophy Energy Metabolism/drug effects Becker BMD muscular dystrophy Inbred mdx LKB1 Inhibitors Morphogenesis Muscular Atrophy Dystrophy Becker muscular dystrophy BMD Muscle CTNNB1 CaVβs Dystrophin-EGFP Long noncoding RNA L-Type Calcium Channels DMD Drp1 Humans Dystrophie Musculaire de Becker BMD Genomic Multi exon skipping Dystrophin Myotendinous junction Dystrophine Gene modifiers Duchenne muscular dystrophy Duchenne DMD dystrophy Mdx mouse Hear Human Umbilical Vein Endothelial Cells Muscle Biology Cell homeostasis Modificateurs de gènes Liver Mice Multi resolution modeling Animals Cardiomyopathy Skeletal muscle LncRNA Homeostasis Hepatocellular carcinoma Long QT Calcium Muscular Dystrophy Muscle development Knockout Myogenesis Exon skipping Activin Receptors Base Sequence Cachexia CD38 Cell Biology Clinical trials Autophagy Dystrophin central domain Animal/physiopathology Muscles/physiopathology Metabolism Dystrophie Musculaire de Duchenne DMD Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Muscular dystrophy Duchenne muscular dystrophy DMD Muscle Strength Inbred C57BL Molecular Sequence Data NAD+ Génomique Cell Line Delivery NNOS MES Dystrophie musculaire de Becker DHPR α1S Molecular docking Mitochondrial fission Male Diseases Gene expression Antisense oligonucleotides CaV subunits BMD DMO Allele‐specific silencing therapy Dynamin 2 Cardiomyopathie Epigenetics Cells Centronuclear myopathy Cultured MiARN Invivo Immunoglobulin Fc Fragments/pharmacology Gene Expression Regulation/drug effects Ex-vivo